179 related articles for article (PubMed ID: 24980078)
1. Thyroid hormone enhanced human hepatoma cell motility involves brain-specific serine protease 4 activation via ERK signaling.
Chen CY; Chung IH; Tsai MM; Tseng YH; Chi HC; Tsai CY; Lin YH; Wang YC; Chen CP; Wu TI; Yeh CT; Tai DI; Lin KH
Mol Cancer; 2014 Jul; 13():162. PubMed ID: 24980078
[TBL] [Abstract][Full Text] [Related]
2. Thyroid hormone-mediated regulation of lipocalin 2 through the Met/FAK pathway in liver cancer.
Chung IH; Chen CY; Lin YH; Chi HC; Huang YH; Tai PJ; Liao CJ; Tsai CY; Lin SL; Wu MH; Chen CY; Lin KH
Oncotarget; 2015 Jun; 6(17):15050-64. PubMed ID: 25940797
[TBL] [Abstract][Full Text] [Related]
3. Stable isotope labeling with amino acids in cell culture (SILAC)-based quantitative proteomics study of a thyroid hormone-regulated secretome in human hepatoma cells.
Chen CY; Chi LM; Chi HC; Tsai MM; Tsai CY; Tseng YH; Lin YH; Chen WJ; Huang YH; Lin KH
Mol Cell Proteomics; 2012 Apr; 11(4):M111.011270. PubMed ID: 22171322
[TBL] [Abstract][Full Text] [Related]
4. Repression of microRNA-130b by thyroid hormone enhances cell motility.
Lin YH; Wu MH; Liao CJ; Huang YH; Chi HC; Wu SM; Chen CY; Tseng YH; Tsai CY; Chung IH; Tsai MM; Chen CY; Lin TP; Yeh YH; Chen WJ; Lin KH
J Hepatol; 2015 Jun; 62(6):1328-40. PubMed ID: 25617495
[TBL] [Abstract][Full Text] [Related]
5. Thyroid hormone receptor represses miR-17 expression to enhance tumor metastasis in human hepatoma cells.
Lin YH; Liao CJ; Huang YH; Wu MH; Chi HC; Wu SM; Chen CY; Tseng YH; Tsai CY; Chung IH; Wu TI; Tsai MM; Lin CD; Lin KH
Oncogene; 2013 Sep; 32(38):4509-18. PubMed ID: 23912452
[TBL] [Abstract][Full Text] [Related]
6. Thyroid hormone regulation of miR-21 enhances migration and invasion of hepatoma.
Huang YH; Lin YH; Chi HC; Liao CH; Liao CJ; Wu SM; Chen CY; Tseng YH; Tsai CY; Lin SY; Hung YT; Wang CJ; Lin CD; Lin KH
Cancer Res; 2013 Apr; 73(8):2505-17. PubMed ID: 23442323
[TBL] [Abstract][Full Text] [Related]
7. Positive regulation of spondin 2 by thyroid hormone is associated with cell migration and invasion.
Liao CH; Yeh SC; Huang YH; Chen RN; Tsai MM; Chen WJ; Chi HC; Tai PJ; Liao CJ; Wu SM; Cheng WL; Pai LM; Lin KH
Endocr Relat Cancer; 2010 Mar; 17(1):99-111. PubMed ID: 19903741
[TBL] [Abstract][Full Text] [Related]
8. Thyroid hormone promotes cell invasion through activation of furin expression in human hepatoma cell lines.
Chen RN; Huang YH; Lin YC; Yeh CT; Liang Y; Chen SL; Lin KH
Endocrinology; 2008 Aug; 149(8):3817-31. PubMed ID: 18467449
[TBL] [Abstract][Full Text] [Related]
9. Cathepsin H regulated by the thyroid hormone receptors associate with tumor invasion in human hepatoma cells.
Wu SM; Huang YH; Yeh CT; Tsai MM; Liao CH; Cheng WL; Chen WJ; Lin KH
Oncogene; 2011 Apr; 30(17):2057-69. PubMed ID: 21217776
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of Interferon-Stimulated Gene 20 by Thyroid Hormone Enhances Angiogenesis in Liver Cancer.
Lin SL; Wu SM; Chung IH; Lin YH; Chen CY; Chi HC; Lin TK; Yeh CT; Lin KH
Neoplasia; 2018 Jan; 20(1):57-68. PubMed ID: 29195126
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of pyruvate kinase M2 isoform inhibits cell motility in hepatocellular carcinoma cells.
Chen YL; Song JJ; Chen XC; Xu W; Zhi Q; Liu YP; Xu HZ; Pan JS; Ren JL; Guleng B
World J Gastroenterol; 2015 Aug; 21(30):9093-102. PubMed ID: 26290635
[TBL] [Abstract][Full Text] [Related]
12. Thyroid hormone receptor inhibits hepatoma cell migration through transcriptional activation of Dickkopf 4.
Chi HC; Liao CH; Huang YH; Wu SM; Tsai CY; Liao CJ; Tseng YH; Lin YH; Chen CY; Chung IH; Wu TI; Chen WJ; Lin KH
Biochem Biophys Res Commun; 2013 Sep; 439(1):60-5. PubMed ID: 23958302
[TBL] [Abstract][Full Text] [Related]
13. Silencing HOXD10 by promoter region hypermethylation activates ERK signaling in hepatocellular carcinoma.
Guo Y; Peng Y; Gao D; Zhang M; Yang W; Linghu E; Herman JG; Fuks F; Dong G; Guo M
Clin Epigenetics; 2017; 9():116. PubMed ID: 29075359
[TBL] [Abstract][Full Text] [Related]
14. The gene regulating activity of thyroid hormone nuclear receptors is modulated by cell-type specific factors.
Lin K; Chen Sl; Zhu XG; Shieh H; McPhie P; Cheng S
Biochem Biophys Res Commun; 1997 Sep; 238(2):280-4. PubMed ID: 9299494
[TBL] [Abstract][Full Text] [Related]
15. Negative modulation of the epigenetic regulator, UHRF1, by thyroid hormone receptors suppresses liver cancer cell growth.
Wu SM; Cheng WL; Liao CJ; Chi HC; Lin YH; Tseng YH; Tsai CY; Chen CY; Lin SL; Chen WJ; Yeh YH; Huang CY; Chen MH; Yeh YC; Lin KH
Int J Cancer; 2015 Jul; 137(1):37-49. PubMed ID: 25430639
[TBL] [Abstract][Full Text] [Related]
16. Direct regulation of androgen receptor-associated protein 70 by thyroid hormone and its receptors.
Tai PJ; Huang YH; Shih CH; Chen RN; Chen CD; Chen WJ; Wang CS; Lin KH
Endocrinology; 2007 Jul; 148(7):3485-95. PubMed ID: 17412801
[TBL] [Abstract][Full Text] [Related]
17. ChIP-on-chip analysis of thyroid hormone-regulated genes and their physiological significance.
Chung IH; Liu H; Lin YH; Chi HC; Huang YH; Yang CC; Yeh CT; Tan BC; Lin KH
Oncotarget; 2016 Apr; 7(16):22448-59. PubMed ID: 26968954
[TBL] [Abstract][Full Text] [Related]
18. Dickkopf 4 positively regulated by the thyroid hormone receptor suppresses cell invasion in human hepatoma cells.
Liao CH; Yeh CT; Huang YH; Wu SM; Chi HC; Tsai MM; Tsai CY; Liao CJ; Tseng YH; Lin YH; Chen CY; Chung IH; Cheng WL; Chen WJ; Lin KH
Hepatology; 2012 Mar; 55(3):910-20. PubMed ID: 21994129
[TBL] [Abstract][Full Text] [Related]
19. HSCs-derived COMP drives hepatocellular carcinoma progression by activating MEK/ERK and PI3K/AKT signaling pathways.
Li Q; Wang C; Wang Y; Sun L; Liu Z; Wang L; Song T; Yao Y; Liu Q; Tu K
J Exp Clin Cancer Res; 2018 Sep; 37(1):231. PubMed ID: 30231922
[TBL] [Abstract][Full Text] [Related]
20. Thyroid hormones suppress FOXM1 expression to reduce liver cancer progression.
Wu CH; Yeh CT; Lin KH
Oncol Rep; 2020 Oct; 44(4):1686-1698. PubMed ID: 32945493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
